Nyad

AI copilot for wastewater treatment operators to diagnose biological conditions and improve plant efficiency.

Cover Block

Public sources

Field	Detail
Company	Nyad
Tagline	AI copilot for wastewater treatment operators to diagnose biological conditions and improve plant efficiency [Hypepotamus, March 2026]
Headquarters	Birmingham, Alabama, United States [Hypepotamus, March 2026] [Techstars, August 2026]
Founded	2024 [Hypepotamus, March 2026]
Stage	Pre-seed [Hypepotamus, March 2026]
Business model	SaaS
Industry	Cleantech / Climatetech
Technology	AI / Machine Learning [Hypepotamus, March 2026]
Geography	North America
Growth profile	Venture Scale
Founding team	Co-Founders (2), Virginia Szepietowski and Christopher Braithwaite [Hypepotamus, March 2026] [Delaware Online, 2026]
Funding label	Pre-seed
Total disclosed	$2.2 million in total equity funding as of March 16, 2026 [AlleyWatch, March 2026]

Executive Summary

PUBLIC Nyad develops an AI copilot for wastewater treatment operators, and it merits investor attention now because it is selling into a labor-constrained, compliance-sensitive workflow where even modest gains in diagnostic speed and decision support can matter operationally [Hypepotamus, March 2026] [Alabama Launchpad, December 2024]. Founded in 2024 in Birmingham, Alabama by Virginia Szepietowski and Christopher Braithwaite, the company traces its origin to the founders’ experience with poor water quality during open-water swimming and triathlon training in the UK, a story that appears consistently across public coverage even if some of the motivational detail remains founder-supplied [Delaware Online, 2026] [Techstars, August 2026].

The product, Nymph, uses digital microscopy and machine learning to interpret activated-sludge biology, classify organisms and floc characteristics, and generate corrective-action guidance, with the practical pitch that plants can get biological insight without adding new sensor hardware or waiting on lab turnaround [Hypepotamus, March 2026] [SiliconANGLE, March 2026] [f4.fund]. The differentiation, as publicly described, sits less in a broad AI claim than in fitting into an existing microscopy workflow that many operators still run manually, while also drawing on plant data such as chemistry, SCADA/WIMS records, manuals, permits, and schedules to support recommendations [Alabama Launchpad, December 2024] [nyad.ai, 2026] [nyad.ai/faq, 2026].

On team, the public record supports a two-founder setup with Szepietowski and Braithwaite identified as British entrepreneurs, and Techstars reported a seven-person team by August 2026 [Delaware Online, 2026] [Techstars, August 2026]. The available background detail is stronger on founder narrative than on prior wastewater operating experience, so the near-term underwriting case rests more on product execution and customer adoption than on a long public resume in utility software [Apple Podcasts, July 2021] [LinkedIn, 2026].

Nyad is a SaaS company at pre-seed stage, and public sources indicate $2.2 million in total equity funding as of March 16, 2026, including a $1.3 million pre-seed led by Boost VC with participation from Draper Associates, Halogen Ventures, Ollin Ventures, Apprentis, First Avenue Ventures, and Troy Wallwork, plus a $25,000 Alabama Launchpad prize in December 2024 [AlleyWatch, March 2026] [Hypepotamus, March 2026] [Alabama Launchpad, December 2024]. Over the next 12 to 18 months, the key watchpoints are whether the company can convert early pilots and multi-state deployments into named reference customers, demonstrate repeatable commercial expansion beyond founder-led selling, and show that its workflow integration produces measurable operator or compliance outcomes at plant level [Techstars, August 2026] [Yahoo Finance, March 2026] [Knox News, March 2026].

Lightly corroborated -- Core company, product, and funding facts are corroborated by multiple public sources, but several team and traction details rely on single-source or company-adjacent reporting.

Taxonomy Snapshot

Axis	Value
Stage	Pre-Seed
Business Model	SaaS
Industry / Vertical	Cleantech / Climatetech
Technology Type	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding	Pre-seed, total disclosed ~$2.2M

How the Company Got Here

PUBLIC

Nyad is a Birmingham, Alabama-based wastewater technology startup founded in 2024 by Virginia Szepietowski and Christopher Braithwaite [Crunchbase]. The company presents itself as an AI software business focused on wastewater treatment operations, with Nymph positioned as a copilot that helps plant teams interpret microscopy, chemistry, SCADA/WIMS data, manuals, permits, schedules, and institutional knowledge into operating recommendations [nyad.ai, 2026].

The chronology that can be supported from the permitted public record is still short, but it is directionally useful. Nyad appears on Crunchbase as a 2024-founded company [Crunchbase], and its own website in 2026 frames the business around wastewater operator decision support rather than hardware deployment [nyad.ai, 2026]. That matters because the company is showing itself to the market first as a software layer for existing plant workflows, which is a narrower and more legible initial scope than a full-stack infrastructure claim [nyad.ai, 2026].

A few early milestones are visible in sequence. In December 2024, Alabama Launchpad awarded Nyad a $25,000 concept-stage prize, a useful local signal even if not venture financing [Alabama Launchpad, December 2024]. By March 2026, Crunchbase reflected a pre-seed financing history for the company [Crunchbase], while the company website in 2026 emphasized a mission of keeping human judgment in command as it adds AI-assisted plant intelligence [nyad.ai/mission, 2026].

Lightly corroborated -- Company identity and founding year are supported by Crunchbase and the company website, but milestone coverage in this section relies partly on a single public program source and company materials.

Product and Technology

Sources and analysis

Nyad’s product story is unusually concrete for a company this early: it is not selling a general AI abstraction, but software aimed at a specific operational bottleneck inside wastewater plants. Public descriptions consistently say the company’s AI copilot, Nymph, uses digital microscopy and machine learning to help wastewater-treatment operators diagnose biological conditions, maintain compliance, and run plants more efficiently [Hypepotamus, March 2026] [SiliconANGLE, March 2026]. On the company’s own materials, Nymph is positioned as a system that turns microscope images, chemistry, SCADA and WIMS data, operating manuals, permits, schedules, and accumulated plant know-how into practical recommendations, while keeping operator judgment central to the decision process [nyad.ai, 2026].

The underlying workflow is also reasonably well described in public. Nyad says Nymph analyzes microscope images to identify and quantify organisms including bacteria, algae, amoebae, flagellates, ciliates, rotifers, and nematodes, and its FAQ states that at 100x magnification the system can identify floc structure and filament presence, then request higher-magnification images or staining when species-level confirmation is needed [SiliconANGLE, March 2026] [nyad.ai/faq, 2026]. Third-party coverage adds that the product combines digital microscopy, computer vision, deep learning, and biological-health models to classify organisms and floc characteristics in activated sludge and provide corrective-action recommendations, although that deeper technical description appears in a secondary profile rather than a primary product document [Fundraising Fox, September 2026].

What stands out is the implementation wedge rather than a claimed hardware moat. Nyad’s public pitch is that plants can get expert guidance and compliance support without adding new sensors or waiting on lab turnaround, replacing slower manual microscopy and paper-based processes with faster biological insight [Alabama Launchpad, December 2024] [f4.fund]. The available job postings suggest the team is still building core product and go-to-market capacity, with a Research Associate, Machine Learning role and a Head of Content role live in early 2026, which supports an inference of an ML-heavy product stack and an early commercial education motion, though the stack details themselves are not otherwise disclosed (inferred from job postings) [Techstars Jobs, February 2026] [LinkedIn Jobs, March 2026].

Lightly corroborated -- Product purpose and workflow are corroborated by company materials and independent press, but several technical details rely on a single secondary profile or company-adjacent sources.

Where the Demand Sits

PUBLIC The market matters now because wastewater plants face a harder operating environment, while the core diagnostic workflow at many facilities still appears manual enough for software to plausibly change daily decisions rather than just reporting on them [Hypepotamus, March 2026] [Alabama Launchpad, December 2024].

Nyad is selling into a wastewater operations stack where the immediate pain point is biological process visibility, not broad utility digitization in the abstract. Public coverage describes the company targeting wastewater treatment operators and utilities, with a product meant to replace slow manual microscopy and "clipboard" workflows with faster image-based diagnosis and corrective guidance [Hypepotamus, March 2026] [Alabama Launchpad, December 2024]. That framing implies a narrower serviceable market than the full water-tech category: the relevant spend sits closer to plant operations, compliance support, and lab-adjacent workflow software than to all utility infrastructure budgets.

The available source set does not provide a third-party TAM, SAM, or SOM for Nyad's exact category, so any sizing exercise here would be analogical rather than company-specific. What can be said from the public record is that Nyad's go-to-market appears oriented toward U.S. wastewater operators across plant sizes, with outside coverage citing both large metropolitan systems and smaller rural plants as target users [Xraise, March 2026]. That breadth expands the possible account base, but it also suggests a fragmented buying environment with varied budgets, technical staffing, and procurement cycles.

A simple way to frame the market is by adjacent budget pools that Nyad may draw from or compete against. The product claims point to overlap with three spending categories: process-control and utility operations software, environmental compliance and reporting tools, and outsourced laboratory or consulting support for microscopy-heavy diagnosis [nyad.ai, 2026] [f4.fund] [SiliconANGLE, March 2026]. The substitute is not only rival software. It is also the incumbent combination of operator judgment, microscopes, spreadsheets, SCADA or WIMS records, manuals, and delayed outside expertise.

Market lens	What public sources support	Relevance to Nyad
Core wedge	Manual microscopy and clipboard-based wastewater workflows remain slow enough to target with software [Alabama Launchpad, December 2024]	Supports a narrow, workflow-level initial market
Buyer set	Utilities and wastewater operators, from large metro systems to small rural plants [Xraise, March 2026]	Suggests broad account count, uneven contract size
Adjacent spend	SCADA, WIMS, chemistry data, permits, schedules, and plant know-how are inputs into recommendations [nyad.ai, 2026]	Indicates adjacency to operations software rather than stand-alone lab hardware
Substitute market	External experts, legacy SOPs, and manual lab interpretation remain the practical alternative [SiliconANGLE, March 2026] [Alabama Launchpad, December 2024]	Implies displacement can come from labor savings and decision speed

The public evidence points to a market that is likely easier to enter through workflow replacement than through full system-of-record displacement. That is constructive for an early company, but it leaves total spend per site and expansion pathways unquantified in the current record.

Demand tailwinds in the source material are concrete even when market size is not. Multiple reports tie Nyad's pitch to an aging wastewater workforce and the loss of operator knowledge, with Hypepotamus explicitly linking the product to retiring operators and Alabama Launchpad emphasizing inefficient manual processes [Hypepotamus, March 2026] [Alabama Launchpad, December 2024]. The company's own materials add a second tailwind: fragmented plant data already exists across microscopy, chemistry, SCADA or WIMS, manuals, permits, and schedules, which creates a plausible opening for a software layer that interprets rather than replaces existing systems [nyad.ai, 2026].

There is also a regulatory logic to the category, even if the present sources stop short of naming specific rulemakings. Wastewater operators are framed repeatedly around compliance, public health, and environmental protection, and Nyad's product is described as helping operators maintain compliance and respond faster to biological conditions [Hypepotamus, March 2026] [SiliconANGLE, March 2026]. In markets where process upsets carry permit risk, customer willingness to pay can be shaped less by headline IT budgets and more by avoided non-compliance, avoided downtime, and reduced reliance on scarce specialist interpretation. That is an inference from the operating context, not a disclosed ROI figure.

Macro conditions cut both ways. On the favorable side, water infrastructure resilience and industrial environmental performance remain durable public priorities, and outside coverage says Nyad is expanding its commercial footprint across the United States [Knox News, March 2026]. On the limiting side, utility procurement tends to be slow, fragmented, and reference-driven, and smaller plants often have thinner technical staffing, which can lengthen adoption even for products that slot into existing microscopy workflows. The absence of public pricing, retention, or named customer references means the current evidence supports demand interest more clearly than it supports category budget depth.

Lightly corroborated -- Market structure and demand drivers are supported by Hypepotamus, Alabama Launchpad, SiliconANGLE, Xraise, and company materials, but this section has no independently sourced third-party TAM, SAM, or SOM for Nyad's exact category.

Competitive Landscape

MIXED Nyad is positioning against a broader set of wastewater workflow alternatives than the record can neatly name, which makes the current contest less about head-to-head vendor displacement and more about whether AI-guided microscopy becomes a budgeted operating system inside plants rather than an add-on tool [Hypepotamus, March 2026] [Alabama Launchpad, December 2024].

The clearest competitive map starts with incumbents and substitutes, not startup peers. On the incumbent side, wastewater plants already rely on established operating systems such as SCADA, WIMS, lab workflows, permits, manuals, and operator judgment, which Nyad itself frames as inputs that Nymph can turn into recommendations rather than systems it fully replaces [nyad.ai, 2026]. On the substitute side, the existing baseline is manual microscopy, clipboard-based diagnosis, external lab turnaround, and in-house process knowledge held by experienced operators, a workflow Nyad says is too slow for real-time biological response [Alabama Launchpad, December 2024] [WMW, 2026]. Public sources also indicate the company is working across utilities that range from large metropolitan systems to smaller rural plants, suggesting the relevant competitive set changes by plant sophistication and staffing depth rather than by a single software category [Xraise, March 2026] [Techstars, August 2026].

Nyad's edge today appears to be product framing and workflow fit, though the durability of that edge is still unproven. The company is not asking plants to install additional sensors, according to investor-facing materials, and instead uses digital microscopy plus machine learning to interpret biological conditions and suggest corrective actions [f4.fund] [Fundraising Fox, September 2026]. That matters because it lowers the operational burden of trial adoption relative to systems that require new hardware or deeper integration work, but it is also a perishable advantage if larger water-tech or industrial software vendors can add image interpretation and advisory layers into products they already distribute [SiliconANGLE, March 2026] [nyad.ai/faq, 2026]. A second edge is category specificity: Nymph is described as identifying organisms and floc characteristics in activated sludge and requesting higher-magnification images or staining when confidence is limited, which suggests a narrower, operations-grade use case than a general-purpose AI copilot claim would imply [SiliconANGLE, March 2026] [nyad.ai/faq, 2026].

The main exposure is channel and proof depth. No named public competitor is confirmed in the source set, but the pressure point is easy to locate: utilities and industrial plants already buy from established water, instrumentation, and compliance vendors with procurement relationships, service footprints, and installed systems that Nyad does not yet appear to own in the public record [Xraise, March 2026] [Knox News, March 2026]. Nyad has disclosed a $1.3 million pre-seed round led by Boost VC and total equity funding of $2.2 million as of mid-March 2026, which is enough to support early commercialization but not enough, on its own, to guarantee a durable field presence in a procurement-heavy market [Hypepotamus, March 2026] [AlleyWatch, March 2026]. The company's reported presence in six states and team of seven show early reach, but they do not yet establish that Nyad owns a repeatable channel, an integration standard, or a reference-customer moat [Techstars, August 2026].

Over the next 18 months, the most plausible competitive scenario is bifurcation between workflow-native specialists and incumbent platforms. The winner if adoption depends on fast deployment and preserving operator know-how is Nyad, because its pitch is tightly tied to existing microscopy workflows and biological diagnostics rather than a wholesale software rip-and-replace [Hypepotamus, March 2026] [Alabama Launchpad, December 2024]. The loser if buyers insist on bundled procurement, long operating histories, and enterprise-wide standardization is likely the standalone copilot category itself, including Nyad, because the public evidence does not yet show named lighthouse customers or a distribution partner that can compress those sales cycles [Techstars, August 2026] [AlleyWatch, March 2026].

Opportunity

Upside case

PUBLIC The prize here is not another point tool for plant diagnostics, but a chance to become the operating layer for biological decision-making inside wastewater treatment, a function that sits close to compliance, labor productivity, and asset efficiency if the product keeps proving accurate in daily use [Hypepotamus, March 2026] [nyad.ai, 2026].

The headline opportunity is straightforward. If Nyad can turn microscopy, chemistry, SCADA or WIMS data, manuals, permits, schedules, and operator knowledge into recommendations that plants trust, it could become the default decision-support system for a fragmented but mission-critical operating environment [nyad.ai, 2026]. That outcome is reachable, not merely aspirational, because the company is already framing the workflow around existing operator behavior rather than asking plants to rip out infrastructure, and public reporting shows both a commercial launch and a funding base sufficient to support early go-to-market and product iteration [Alabama Launchpad, December 2024] [SiliconANGLE, March 2026] [AlleyWatch, March 2026].

A second reason the upside is real is that Nyad appears to be selling into a problem with operational urgency. Public coverage repeatedly ties the product to slow manual microscopy, compliance pressure, and the retirement of experienced operators, which suggests the software is not being positioned as discretionary analytics but as practical help for understaffed plants [Hypepotamus, March 2026] [Yahoo Finance, March 2026]. The evidence is still early, and customer names are not public, but a product that shortens diagnosis time while preserving institutional know-how can matter disproportionately in a sector where expertise is unevenly distributed [Techstars, August 2026] [WMW].

Scenario	What happens	Catalyst	Why it's plausible
Microscopy copilot becomes standard workflow	Nyad wins routine use at utilities and industrial wastewater sites, starting with biological diagnostics and expanding into broader operating recommendations	Commercial launch plus continued adoption across multiple states creates a reference base for repeat sales [SiliconANGLE, March 2026] [Techstars, August 2026]	The product is built around existing microscopy and plant data rather than new hardware, lowering workflow friction, and the company says it already operates in six states [nyad.ai/faq, 2026] [Techstars, August 2026]
Compliance and knowledge-retention platform	Nyad moves from image interpretation into an always-on assistant that helps new operators interpret permits, manuals, schedules, and plant history	Aging workforce pressure makes software that captures tacit expertise more valuable to managers and utilities [Hypepotamus, March 2026] [nyad.ai, 2026]	Public product materials already describe Nymph as combining microscope images with operational context, which is a broader wedge than image classification alone [nyad.ai, 2026] [Fundraising Fox, September 2026]
Channel-driven national rollout	Nyad uses investor, accelerator, and industry relationships to shorten sales cycles and reach a larger utility footprint across the U.S.	The March 2026 pre-seed and Techstars network support hiring and customer access [Hypepotamus, March 2026] [Techstars, August 2026]	The company has already raised outside capital from venture firms and strategic angels and is hiring into machine learning and content, both consistent with product maturation and category education [AlleyWatch, March 2026] [Techstars Jobs, February 2026] [LinkedIn Jobs, March 2026]

These scenarios point to the same underlying dynamic: a narrow operational wedge can expand if trust accumulates. In wastewater, operators do not need generalized AI. They need a system that helps them interpret what is happening in the basin, tie that reading to corrective action, and do so in a way that stands up under compliance scrutiny [Hypepotamus, March 2026] [Fundraising Fox, September 2026].

What compounding looks like is a data and workflow flywheel. Each new plant potentially adds more microscopy images, more edge cases in activated sludge, and more context on how biological conditions map to recommended interventions, which should improve classification and recommendation quality over time if the company can maintain disciplined labeling and feedback loops [Fundraising Fox, September 2026] [nyad.ai/faq, 2026]. The early signs are modest but visible: Nyad has launched commercially, reports operations in six states, and has built the product to ingest not only images but also plant documents and operational systems, which broadens switching costs once embedded in routine work [SiliconANGLE, March 2026] [Techstars, August 2026] [nyad.ai, 2026].

There is also a distribution compounding effect if the company can serve both large metropolitan systems and smaller rural plants with the same core software motion, as reported in public materials [Xraise, March 2026]. A product that does not require additional sensors and can work with existing microscopes and plant records has a better chance of spreading across a heterogeneous installed base, and that matters in a sector where procurement budgets and technical staffing vary widely [f4.fund] [Alabama Launchpad, December 2024].

The size of the win is harder to pin down because the provided source set does not include a confirmed market size or a named public comparable in wastewater operations software. Even so, a useful framing is strategic value rather than near-term revenue math: if Nyad became the trusted software layer for biological diagnostics and operator guidance across U.S. wastewater plants, it could plausibly resemble the kind of vertical industrial software asset that strategic infrastructure, compliance, or water-tech buyers would pay a premium to own (scenario, not a forecast) [Hypepotamus, March 2026] [nyad.ai, 2026]. The public evidence supports the existence of the wedge, the early financing to pursue it, and initial geographic spread. It does not yet support a precise valuation range, so the upside case is best stated as category position first, valuation second.

Lightly corroborated -- Built primarily from company materials and startup press, with partial corroboration from AlleyWatch, Alabama Launchpad, and Techstars.

Sources